|
|
|
30.10.26 - 08:06
|
Optomed′s January-September 2026 interim report will be published on 6 November 2026 (Cision)
|
|
|
Optomed Plc Press Release 30 October 2026 at 9.00, Helsinki
Optomed's January-September 2026 interim report will be published on 6 November 2026
Optomed will publish its January-September 2026 interim report on 6 November 2026 approximately at 9.00 EET.
A telephone conference for analysts, investors and media will be arranged on the publishing day at 11.00 EET/10.00 CET. The event will be held in English. The presentation material will be available at www.optomed.com/investors 10.00 EET at the latest.
The participants are requested to register for the call in advance...
|
|
|
|
|
|
|
|
|
|
|
|
|
23.10.26 - 01:36
|
Correction: The Board of Directors of Bioretec Ltd resolved on a new stock option plan (Cision)
|
|
|
Bioretec Ltd — Company Announcement — 23 October 26 at 2.35 EEST
Bioretec Ltd corrects and supplements its company announcements of 1 June 2026 and 7 July 2026 concerning the Board of Directors' resolution to establish a new stock option plan. The earlier announcements did not specify that the share subscription price stated therein does not apply to all of the options: under the terms and conditions of the plan, certain terms may vary by jurisdiction, and for a portion of the options the share subscription price is determined on the basis of the fair market value of the share to comply...
|
|
|
|
|
|
|
|
|
21.10.26 - 08:30
|
Orion Lifts FY26 Outlook (AFX)
|
|
|
HELSINKI (dpa-AFX) - Orion Oyj (ORNBV.HE), a Nordic pharmaceutical company, Tuesday said that it is raising its fiscal 2026 net sales and operating profit outlook as royalty income has increased f......
|
|
|
|
|
|
|
|
|
|
|
12.10.26 - 17:01
|
Composition of Bioretec′s Shareholders′ Nomination Board (Cision)
|
|
|
Bioretec Ltd, Company release, 12 October 2026 at 6:00 p.m. EEST
The following persons have been appointed to Bioretec's Shareholders' Nomination Board: Tor-Oskar Karlberg from Stephen Industries Inc Oy, Rami Vehmas from Keskinäinen Eläkevakuutusyhtiö Ilmarinen and Johan Hamström from Sp-Rahastoyhtiö Oy.
The Nomination Board has elected Tor-Oskar Karlberg as its chairperson at its organizational meeting on 12 October, 2026.
The chairperson of the Board of Directors of Bioretec acts as an expert to the Nomination Board without voting right.
In accordance with the Charter of the...
|
|
|
|
|
08.10.26 - 15:00
|
Inside information: Bioretec initiates change negotiations to improve operational efficiency and competitiveness (Cision)
|
|
|
Bioretec Ltd, Inside Information, 8 October 2026 at 4:00 p.m. EEST
Bioretec Ltd will initiate change negotiations in accordance with the Co-operation Act as part of the development of the company's organization and operating model. The objective of the negotiations is to strengthen the company's performance, improve operational efficiency, and enhance Bioretec's competitiveness and long-term growth prospects.
The change negotiations are part of a broader organizational and operating model transformation aimed at creating a clearer, more efficient organization that better supports the...
|
|
|
|
|
07.10.26 - 13:01
|
Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings (Cision)
|
|
|
Optomed Plc Stock Exchange Release 7 October 2026 at 14.00, Helsinki
Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings
Optomed Plc (“Optomed” or the “Company”) has received a notification in accordance with Chapter 9, Section 5 of the Finnish Securities Markets Act (as amended, the “SMA”) from Sp-Rahastoyhtiö Oy (“Notifier”). According to the notification, the aggregate holding of the investment funds managed by Sp-Rahastoyhtiö Oy, Säästöpankki Pienyhtiöt and Säästöpankki Kotimaa, in Optomed's shares and voting rights amounted to 4.91...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
